To assess the effect of curcumin on MDSCs in vivo, we conducted a flow cytometric analysis of Gr1+CD11b+ splenocytes from 4T1 tumor-bearers treated with curcumin or DMSO control. This evidence concerns the gene ITGAM and neoplasm.